Hoda Pourhassan

Hoda Pourhassan practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Hoda Pourhassan's NPI, 1942543319, was assigned on April 3, 2013. Hoda Pourhassan graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2013. Hoda Pourhassan's California license number on file is A140737.

Hoda Pourhassan's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Hoda Pourhassan's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Hoda Pourhassan is also affiliated with City of Hope Cancer Center Chicago. The medical group on file is City of Hope. Dmand AI also links Hoda Pourhassan to 1 more other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hoda Pourhassan practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Hoda Pourhassan's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Hoda Pourhassan is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Hoda Pourhassan's licenses on file in 2 states: California and Illinois.

Dmand AI lists anemia, chronic anemia, chronic leukemia, multiple myeloma and neutropenia among the conditions Hoda Pourhassan treats.

CMS data shows 683 Medicare services from Hoda Pourhassan across 3 procedure codes in 2024, for 118 Medicare patients. Medicare paid $71,533 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 118 Medicare patients who saw Hoda Pourhassan in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 33% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hoda Pourhassan's median patient age at 61, with 51% women.

In 2024, Hoda Pourhassan wrote 44 Medicare Part D claims for 16 patients. 64% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $24,105 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Hoda Pourhassan for performance year 2024, reported as part of a group. Hoda Pourhassan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 39 papers to Hoda Pourhassan, published from 2017 to 2025. 2024 was the busiest year, with 16. The most frequent topics are Hematopoietic Stem Cell Transplantation, Precursor Cell Lymphoblastic Leukemia-Lymphoma and Graft vs Host Disease. Hoda Pourhassan has published most often in Transplant Cell Ther. Hoda Pourhassan's most frequent co-authors are Vaibhav Agrawal, MD, Vinod Pullarkat, MD and Guido Marcucci, MD.

CMS Open Payments shows 14 general payments to Hoda Pourhassan from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 53% of the total. Jazz Pharmaceuticals Inc. paid the most, $164.

Hoda Pourhassan graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2013.

Hoda Pourhassan is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.